WuXi AppTec (OTCMKTS:WUXAY) Sees Large Volume Increase – Should You Buy?

Shares of WuXi AppTec Co., Ltd. (OTCMKTS:WUXAYGet Free Report) saw unusually-high trading volume on Monday . 4,049 shares were traded during mid-day trading, an increase of 85% from the previous session’s volume of 2,186 shares.The stock last traded at $24.74 and had previously closed at $24.98.

Analysts Set New Price Targets

Separately, Zacks Research raised WuXi AppTec to a “hold” rating in a report on Monday, April 13th. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy”.

View Our Latest Stock Report on WUXAY

WuXi AppTec Trading Up 0.9%

The firm has a 50-day simple moving average of $18.79 and a 200-day simple moving average of $16.61.

WuXi AppTec Company Profile

(Get Free Report)

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.

Featured Articles

Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.